AP2112A - yd-Crystalline form of Ivabradine Hydrochloride, aprocess for its preparation and pharmaceutical co mpositions containing it - Google Patents

yd-Crystalline form of Ivabradine Hydrochloride, aprocess for its preparation and pharmaceutical co mpositions containing it

Info

Publication number
AP2112A
AP2112A AP2006003522A AP2006003522A AP2112A AP 2112 A AP2112 A AP 2112A AP 2006003522 A AP2006003522 A AP 2006003522A AP 2006003522 A AP2006003522 A AP 2006003522A AP 2112 A AP2112 A AP 2112A
Authority
AP
ARIPO
Prior art keywords
aprocess
pharmaceutical
preparation
crystalline form
ivabradine hydrochloride
Prior art date
Application number
AP2006003522A
Other languages
English (en)
Other versions
AP2006003522A0 (en
Inventor
Stephanie Horvath
Marie-Noelle Auguste
Gerard Damien
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AP2006003522A0 publication Critical patent/AP2006003522A0/xx
Application granted granted Critical
Publication of AP2112A publication Critical patent/AP2112A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Seasonings (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
AP2006003522A 2005-02-28 2006-02-22 yd-Crystalline form of Ivabradine Hydrochloride, aprocess for its preparation and pharmaceutical co mpositions containing it AP2112A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0501990A FR2882556B1 (fr) 2005-02-28 2005-02-28 Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent

Publications (2)

Publication Number Publication Date
AP2006003522A0 AP2006003522A0 (en) 2006-02-28
AP2112A true AP2112A (en) 2010-03-03

Family

ID=34954879

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2006003522A AP2112A (en) 2005-02-28 2006-02-22 yd-Crystalline form of Ivabradine Hydrochloride, aprocess for its preparation and pharmaceutical co mpositions containing it

Country Status (43)

Country Link
US (3) US7361651B2 (xx)
EP (1) EP1695709B1 (xx)
JP (1) JP4628975B2 (xx)
KR (1) KR100827503B1 (xx)
CN (1) CN100432057C (xx)
AP (1) AP2112A (xx)
AR (1) AR056931A1 (xx)
AT (1) ATE397933T1 (xx)
AU (1) AU2006200855B2 (xx)
BR (1) BRPI0600696A (xx)
CA (1) CA2537404C (xx)
CO (1) CO5770095A1 (xx)
CR (1) CR8246A (xx)
CU (1) CU23615B7 (xx)
CY (1) CY1108220T1 (xx)
DE (1) DE602006001411D1 (xx)
DK (1) DK1695709T3 (xx)
EA (1) EA008532B1 (xx)
EC (1) ECSP066376A (xx)
ES (1) ES2308688T3 (xx)
FR (1) FR2882556B1 (xx)
GE (1) GEP20084468B (xx)
GT (1) GT200600086A (xx)
HK (1) HK1096660A1 (xx)
HR (1) HRP20080417T5 (xx)
IL (1) IL173960A0 (xx)
MA (1) MA28132A1 (xx)
ME (2) ME01394B (xx)
MY (1) MY157933A (xx)
NO (1) NO338482B1 (xx)
NZ (1) NZ545579A (xx)
PE (1) PE20061070A1 (xx)
PL (1) PL1695709T3 (xx)
PT (1) PT1695709E (xx)
RS (1) RS50600B (xx)
SA (1) SA06270041B1 (xx)
SG (1) SG125233A1 (xx)
SI (1) SI1695709T1 (xx)
TW (1) TWI314142B (xx)
UA (1) UA81340C2 (xx)
UY (1) UY29407A1 (xx)
WO (1) WO2006092494A1 (xx)
ZA (1) ZA200601760B (xx)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2882555B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882553B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882554B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme critalline beta d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882556B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2891827B1 (fr) * 2005-10-11 2007-12-28 Servier Lab Forme cristalline deltad du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2891826B1 (fr) * 2005-10-11 2007-12-28 Servier Lab Forme cristalline 6 du chlorhydrate de l'ivabradine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
EP2097383B1 (en) 2006-11-30 2012-02-08 Cadila Healthcare Limited Process for preparation of ivabradine hydrochloride
CN101353325B (zh) * 2007-07-27 2011-11-09 上海优拓医药科技有限公司 稳定型盐酸伊伐布雷定结晶及其制备方法
PT2471780E (pt) 2007-05-30 2015-02-24 Ind Swift Lab Ltd Sais oxalato de ivabradina cristalinos e seus polimorfos
CN102264689B (zh) 2008-12-22 2014-12-31 新梅斯托克尔卡公司 制备伊伐布雷定的方法
CN101774969B (zh) 2009-01-13 2012-07-04 江苏恒瑞医药股份有限公司 硫酸伊伐布雷定及其i型结晶的制备方法
EP2534135A2 (en) 2010-02-12 2012-12-19 KRKA, D.D., Novo Mesto Novel forms of ivabradine hydrochloride
HUP1000245A2 (en) 2010-05-07 2011-11-28 Richter Gedeon Nyrt Industrial process for the production ivabradin salts
WO2012025940A1 (en) 2010-08-25 2012-03-01 Cadila Healthcare Limited Polymorphic form of ivabradine hydrochloride and process for preparation thereof
WO2013017582A1 (en) 2011-08-02 2013-02-07 Sandoz Ag Acetone solvate of ivabradine hydrochloride
EP2773621B1 (en) 2011-11-04 2015-12-30 Synthon BV A process for making crystalline delta-form of ivabradine hydrochloride
EP2589594A1 (en) * 2011-11-04 2013-05-08 Urquima S.A. Ivabradine hydrochloride Form IV
US9120755B2 (en) 2011-11-14 2015-09-01 Cadila Healthcare Limited Polymorphic forms of ivabradine hydrochloride
WO2014114341A1 (en) 2013-01-24 2014-07-31 Synthon Bv Process for making ivabradine
CZ2013767A3 (cs) 2013-10-02 2015-04-29 Zentiva, K.S. Pevná forma Ivabradin hydrochloridu a (S)-mandlové kyseliny a její farmaceutická kompozice
ES2672472T3 (es) 2013-12-12 2018-06-14 Synthon Bv Composición farmacéutica que comprende ivabradina amorfa
EP2774606B1 (en) 2014-02-14 2019-01-30 Synthon B.V. Pharmaceutical composition comprising ivabradine hydrochloride polymorph IV
CZ2014478A3 (cs) 2014-07-10 2015-09-16 Zentiva, K.S. Pevná forma Ivabradin hydrochloridu a (R)-mandlové kyseliny a její farmaceutická kompozice
TWI598360B (zh) * 2016-12-19 2017-09-11 義守大學 Ｆｓｂｍ重組蛋白及其用途
TR201703066A2 (tr) 2017-02-28 2018-09-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi İvabradi̇ni̇n kati oral farmasöti̇k kompozi̇syonlari
EP3366282A1 (en) 2017-02-28 2018-08-29 Sanovel Ilac Sanayi ve Ticaret A.S. Solid oral pharmaceutical compositions of ivabradine
IT202000025312A1 (it) 2020-10-26 2022-04-26 Cambrex Profarmaco Milano S R L Processi per la preparazione di polimorfi di ivabradina hcl

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0534859A1 (fr) * 1991-09-27 1993-03-31 Adir Et Compagnie 3-Benzazépin-zones substituées par un groupe benzocyclobutyl- ou indanyl-alkyl-amino-alkyle, utiles dans le traitement des affections cardiovasculaires

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US534859A (en) * 1895-02-26 Condenser for ice-machines
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
DE3418270A1 (de) * 1984-05-17 1985-11-21 Dr. Karl Thomae Gmbh, 7950 Biberach Neue aminotetralinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
ATE227992T1 (de) 1990-08-29 2002-12-15 Humanetics Corp Behandlungsverfahren zur förderung des gewichtsverlustes unter verwendung eines substituierten delta-5-androstens
FR2818552B1 (fr) 2000-12-26 2003-02-07 Servier Lab Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2882555B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882556B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882554B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme critalline beta d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882553B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2891827B1 (fr) * 2005-10-11 2007-12-28 Servier Lab Forme cristalline deltad du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2891826B1 (fr) * 2005-10-11 2007-12-28 Servier Lab Forme cristalline 6 du chlorhydrate de l'ivabradine, son procede de preparation et les compositions pharmaceutiques qui la contiennent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0534859A1 (fr) * 1991-09-27 1993-03-31 Adir Et Compagnie 3-Benzazépin-zones substituées par un groupe benzocyclobutyl- ou indanyl-alkyl-amino-alkyle, utiles dans le traitement des affections cardiovasculaires

Also Published As

Publication number Publication date
CA2537404C (fr) 2010-04-13
SA06270041B1 (ar) 2010-03-08
KR20060095503A (ko) 2006-08-31
WO2006092494A1 (fr) 2006-09-08
AP2006003522A0 (en) 2006-02-28
NZ545579A (en) 2007-01-26
ES2308688T3 (es) 2008-12-01
FR2882556A1 (fr) 2006-09-01
US20080153804A1 (en) 2008-06-26
DE602006001411D1 (de) 2008-07-24
ZA200601760B (en) 2008-04-30
GT200600086A (es) 2006-11-02
US7361651B2 (en) 2008-04-22
IL173960A0 (en) 2006-07-05
ECSP066376A (es) 2006-11-16
TWI314142B (en) 2009-09-01
AU2006200855B2 (en) 2010-12-23
ME02750B (me) 2010-05-07
UY29407A1 (es) 2006-07-31
PE20061070A1 (es) 2006-11-18
NO338482B1 (no) 2016-08-22
JP2006241157A (ja) 2006-09-14
ATE397933T1 (de) 2008-07-15
CU20060038A7 (es) 2008-06-30
DK1695709T3 (da) 2008-09-29
AR056931A1 (es) 2007-11-07
CN1827601A (zh) 2006-09-06
HK1096660A1 (xx) 2007-06-08
RS50600B (sr) 2010-05-07
MY157933A (en) 2016-08-15
BRPI0600696A (pt) 2007-05-08
SI1695709T1 (sl) 2008-10-31
US20090318420A1 (en) 2009-12-24
CO5770095A1 (es) 2007-06-29
JP4628975B2 (ja) 2011-02-09
FR2882556B1 (fr) 2007-05-04
EP1695709A1 (fr) 2006-08-30
EA008532B1 (ru) 2007-06-29
SG125233A1 (en) 2006-09-29
US7872001B2 (en) 2011-01-18
AU2006200855A1 (en) 2006-09-14
ME01394B (me) 2013-12-20
CA2537404A1 (fr) 2006-08-28
EP1695709B1 (fr) 2008-06-11
CR8246A (es) 2008-01-21
HRP20080417T3 (en) 2008-09-30
PT1695709E (pt) 2008-07-04
MA28132A1 (fr) 2006-09-01
UA81340C2 (en) 2007-12-25
US20060194964A1 (en) 2006-08-31
CN100432057C (zh) 2008-11-12
NO20060949L (no) 2006-08-29
GEP20084468B (en) 2008-08-25
TW200640871A (en) 2006-12-01
HRP20080417T5 (en) 2008-11-30
CY1108220T1 (el) 2014-02-12
KR100827503B1 (ko) 2008-05-06
EA200600323A1 (ru) 2006-08-25
PL1695709T3 (pl) 2008-10-31
CU23615B7 (es) 2011-01-27

Similar Documents

Publication Publication Date Title
AP2112A (en) yd-Crystalline form of Ivabradine Hydrochloride, aprocess for its preparation and pharmaceutical co mpositions containing it
AP2006003757A0 (en) ?d-Crystalline form of ivabradine hydrochloride, aprocess for its preparation and pharmaceutical co mpositions containing it
TWI315306B (en) Bd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
AP2303A (en) d-Crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it.
ZA200601762B (en) ß-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
AP2006003521A0 (en) Y-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it.
SI1913001T1 (sl) (r)-n-metilnaltrekson, postopki za njega sintezo in njega farmacevtsko uporabo
ME02026B (me) Novi kristalni v oblik agomelatina, postupak za njegovu proizvodnju i farmaceutske smiješe koje ga sadrže
SI1707564T1 (sl) Indanil-piperazinski derivati, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo
IL192963A0 (en) Rimonabant monohydrate, process for the preparation thereof and pharmaceutical compositions containing same
AU2006200857B2 (en) y-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
AU2006200854B2 (en) bd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
AU2006200856B2 (en) beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it